Form 4: Celanese Corp Director Michael Koenig Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Michael Koenig reports acquiring and disposing of Celanese Corp common stock related to a restricted stock unit grant.
Summary
- On May 9, 2025, Michael Koenig, a director of Celanese Corp, reported a transaction involving the company's common stock.
- Koenig acquired 3,376 shares of common stock through an annual grant of restricted stock units under the company's 2018 Global Incentive Plan.
- The restricted stock units vest in full on the one-year anniversary of the grant date.
- Concurrently, Koenig disposed of 3,376 shares.
- Following the reported transactions, Koenig beneficially owns 6,693 shares of Celanese Corp common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by a company director, indicating a neutral sentiment.
Positives
- The grant of restricted stock units aligns the director's interests with the company's performance.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects routine executive compensation.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of transaction: Acquisition and disposal of Celanese Corp common stock. |
| 05/13/2025 | Date of signature on the Form 4 filing. |
Keywords
Celanese Corp, Michael Koenig, Form 4, Director, Stock, Restricted Stock Units, Beneficial Ownership, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.